Drug Type Small molecule drug |
Synonyms PGE1(Gurus), Prostaglandin E1(Gurus) + [1] |
Action antagonists, modulators |
Mechanism EP1 antagonists(Prostanoid EP1 receptor antagonists), EP4 antagonists(Prostanoid EP4 receptor antagonists), PGI2 receptor modulators(Prostanoid IP receptor modulators) + [1] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peripheral Arterial Disease | Phase 1 | - | - | |
| Chronic Limb-Threatening Ischemia | Preclinical | Russia | 22 Sep 2024 | |
| Raynaud Disease | Preclinical | Russia | 22 Sep 2024 |





